CTRI/2024/05/066781尚未招募Unknown
Impact Of 0.1% nepafenac on macular and choroidal thickness after uncomplicated Phacoemulsification surgery - nil
nil0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Diabetic patients with no clinical evidence of diabetic retinopathy who have senile immature cataract (gr 2, gr 3) scheduled to undergo cataract extraction and posterior chamber Intra-ocular lens implantation
排除标准
- •1. Anterior segment pathology (corneal opacities, PEX, dense cataract)
- •2. Posterior segment pathology (DR, ARMD, retinal vascular diseases, uveitis)
- •3. Intra & Postoperative complications(TASS, raised IOP)
- •4.History of chronic oral/topical medication, intraocular surgery, ocular trauma.
研究者
相似试验
招募中
不适用
Priventive effect of nepafenac ophtalmic solution for changing of foveal thickness after cataract surgery.macular edema after cataract surgeryJPRN-UMIN000006671Tokyo women's medical university diabetic center opthalmology depertment60
已完成
不适用
Study of effects on the retina and the choroid of intravitreal ranibizmab injection in patients with macular edema due to central retinal vein occlusion.central retinal vein occlusionJPRN-UMIN000029921agasaki University Hospital30
撤回
3 期
Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgeryocular inflammation and pain after cataract surgery10015919NL-OMON34348Alcon Laboratories120
进行中（未招募）
不适用
Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery - Confirmatory Study Nepafenac 0.3%The Prevention and Treatment of Ocular Inflammation and Pain after Cataract SurgeryEUCTR2010-019507-28-SEAlcon Research, Ltd.2,000
进行中（未招募）
不适用
Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery - Confirmatory Study Nepafenac 0.3%The prevention and treatment of ocular inflammation and pain after cataract surgery.MedDRA version: 9.1Level: LLTClassification code 10015943MedDRA version: 9.1Level: LLTClassification code 10015958EUCTR2010-019507-28-ITAlcon Research, Ltd.2,000